Prediction of survival in patients with head and neck cancer using the histoculture drug response assay

Chemoresponse is a significant outcome predictor in patients with head and neck cancer, regardless of the treatment modality used. The histoculture drug response assay (HDRA) has been shown to be a reliable method for in vitro chemoresponse assessment. In this study, we have correlated the HDRA assessment with survival in patients with head and neck squamous cell carcinoma (HNSCC).

[1]  M. Mahé,et al.  Final Results of a Randomized Trial Comparing Chemotherapy Plus Radiotherapy With Chemotherapy Plus Surgery Plus Radiotherapy in Locally Advanced Resectable Hypopharyngeal Carcinomas , 1997, The Laryngoscope.

[2]  S. Steinberg,et al.  Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  H. Sasano,et al.  Potential of the histoculture drug-response assay to contribute to cancer patient survival. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  R. Hoffman,et al.  Clinical applications of the histoculture drug response assay. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  R. Hoffman,et al.  Sponge-gel-supported histoculture drug-response assay for head and neck cancer. Correlations with clinical response to cisplatin. , 1994, Archives of otolaryngology--head & neck surgery.

[6]  S. Lippman,et al.  Recent advances in head and neck cancer--larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. , 1993, Cancer research.

[7]  S. Steinberg,et al.  Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. , 1993, Cancer research.

[8]  R. Hoffman,et al.  In vitro assays for chemotherapy sensitivity. , 1993, Critical reviews in oncology/hematology.

[9]  Masahiko Watanabe,et al.  High in vitro‐in vivo correlation of drug response using sponge‐gel‐supported three‐dimensional histoculture and the MTT end point , 1992, International journal of cancer.

[10]  A. Forastiere.  Randomized trials of induction chemotherapy. A critical review. , 1991, Hematology/oncology clinics of North America.

[11]  R. Kronmal,et al.  A southwest oncology group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer , 1991, Cancer.

[12]  W. Hong,et al.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. , 1991, The New England journal of medicine.

[13]  M. Piccart,et al.  Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. , 1990, Journal of the National Cancer Institute.

[14]  S. Steinberg,et al.  Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial. , 1990, Journal of the National Cancer Institute.

[15]  F. Cognetti,et al.  Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  W. Fee,et al.  Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the northern California oncology group , 1987, Cancer.

[17]  C. Redfern,et al.  In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Jacobs,et al.  Induction chemotherapy in advanced head and neck cancer. A Radiation Therapy Oncology Group Study. , 1987, Archives of otolaryngology--head & neck surgery.

[19]  L. Weisenthal,et al.  A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. , 1983, Cancer research.

[20]  J. H. Scarffe,et al.  Cancer Medicine , 1982, British Journal of Cancer.

[21]  J. Leighton.  A sponge matrix method for tissue culture; formation of organized aggregates of cells in vitro. , 1951, Journal of the National Cancer Institute.

[22]  S. Steinberg,et al.  Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: Comparison of non‐small cell lung cancer and small cell lung cancer , 1996, Journal of cellular biochemistry. Supplement.

[23]  M. Tsukuda,et al.  Induction chemotherapy in advanced head and neck cancer. , 1994, Auris, nasus, larynx.

[24]  R. Hoffman,et al.  To do tissue culture in two or three dimensions? that is the question , 1993, Stem cells.

[25]  T. Furukawa,et al.  Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point. , 1992, Anticancer research.

[26]  R. Hoffman.  In vitro sensitivity assays in cancer: A review, analysis, and prognosis , 1991, Journal of clinical laboratory analysis.